Table 1. Clinical cases of neurotoxic envenomations.
French departement | Alpes-de-Haute-Provence (04) | Alpes-Maritimes (06) | Aveyron (12) | Hérault (34) | Total |
Case number | 3 | 7 | 3 | 1 | 14 |
M/F | 2/1 | 5/2 | 2/1 | Not mentionned | 9/4 |
Age in years (mini/maxi) | 48/88 | 32/68 | 4/62 | 5 | 4/88 |
Years | 1995 to 1999 | 1992 to 2005 | 1998 to 2004 | 2001 | 1992 to 2005 |
Grade 1/2/3 number | 0/2/1 | 0/6/1 | 0/3/0 | 0/1/0 | 0/12/2 |
Local signs | |||||
Local swelling | 1 | 3 | 2 | 1 | 7 |
Extensive swelling | 2 | 4 | 1 | 0 | 7 |
Neurological signs | |||||
Ptosis | 3 | 7 | 3 | 1 | 14 (100%) |
Ophtalmoplegia | 2 | 5 | 2 | 1 | 10 (71%) |
Drowsiness | 1 | 4 | 2 | 1 | 9 (64%) |
Dysphagia | 2 | 3 | 1 | 1 | 7 (50%) |
Dysphonia | 0 | 4 | 1 | 1 | 6 (43%) |
Vision troubles * | 1 | 3 | 1 | 0 | 5 (36%) |
Paresthesia | 0 | 3 | 1 | 0 | 4 (29%) |
Muscle weakness | 0 | 1 | 1 | 0 | 4 (14%) |
Lip paralysis | 0 | 2 | 2 | 0 | 4 (28%) |
Agueusia | 0 | 1 | 0 | 0 | 1 (7%) |
Other systemic symptoms | 3 | 7 | 3 | 0 | 13 (93%) |
Antivenom treatment | 3 | 4 | 2 | 1 | 10 (71%) |
accomodation trouble, diplopia